Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24670521)

1.

Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.

Kapetanovic S, Griner R, Zeldow B, Nichols S, Leister E, Gelbard HA, Miller TL, Hazra R, Mendez AJ, Malee K, Kammerer B, Williams PL; Pediatric HIV/AIDS Cohort Study Team.

AIDS. 2014 Jan 28;28(3):355-64. doi: 10.1097/QAD.0000000000000072.

2.

Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Kapetanovic S, Leister E, Nichols S, Miller T, Tassiopoulos K, Hazra R, Gelbard HA, Malee KM, Kammerer B, Mendez AJ, Williams PL; Pediatric HIV/AIDS Cohort Study Team.

AIDS. 2010 Jun 19;24(10):1481-91. doi: 10.1097/QAD.0b013e32833a241b.

3.

Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

Miller TI, Borkowsky W, DiMeglio LA, Dooley L, Geffner ME, Hazra R, McFarland EJ, Mendez AJ, Patel K, Siberry GK, Van Dyke RB, Worrell CJ, Jacobson DL; Pediatric HIV/AIDS Cohort Study (PHACS), Shearer W, Cooper N, Harris L, Purswani M, Baig M, Cintron A, Puga A, Navarro S, Patton D, Burchett S, Karthas N, Kammerer B, Yogev R, Malee K, Hunter S, Cagwin E, Wiznia A, Burey M, Nozyce M, Chen J, Gobs E, Grant M, Knapp K, Allison K, Garvie P, Acevedo-Flores M, Rios H, Olivera V, Silio M, Borne C, Sirois P, Spector S, Norris K, Nichols S, McFarland E, Barr E, Chambers C, Watson D, Messenger N, Belanger R, Dieudonne A, Bettica L, Adubato S, Scott G, Himic L, Willen E.

HIV Med. 2012 May;13(5):264-75. doi: 10.1111/j.1468-1293.2011.00970.x. Epub 2011 Dec 4.

4.

Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Miller TL, Somarriba G, Orav EJ, Mendez AJ, Neri D, Schaefer N, Forster L, Goldberg R, Scott GB, Lipshultz SE.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):182-8. doi: 10.1097/QAI.0b013e3181e222c9.

5.

Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence.

Smith R, Chernoff M, Williams PL, Malee KM, Sirois PA, Kammerer B, Wilkins M, Nichols S, Mellins C, Usitalo A, Garvie P, Rutstein R; Pediatric HIV/AIDS Cohort Study (PHACS) Team.

Pediatr Infect Dis J. 2012 Jun;31(6):592-8. doi: 10.1097/INF.0b013e318253844b.

6.

Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth.

Alperen J, Brummel S, Tassiopoulos K, Mellins CA, Kacanek D, Smith R, Seage GR 3rd, Moscicki AB.

J Adolesc Health. 2014 Mar;54(3):341-9. doi: 10.1016/j.jadohealth.2013.09.003. Epub 2013 Nov 13.

7.

Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure.

Malee KM, Tassiopoulos K, Huo Y, Siberry G, Williams PL, Hazra R, Smith RA, Allison SM, Garvie PA, Kammerer B, Kapetanovic S, Nichols S, Van Dyke R, Seage GR 3rd, Mellins CA; Pediatric HIV/AIDS Cohort Study Team.

AIDS Care. 2011 Dec;23(12):1533-44. doi: 10.1080/09540121.2011.575120.

8.

Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy.

Guzmán-Fulgencio M, Medrano J, Rallón N, Echeverria-Urabayen A, Miguel Benito J, Restrepo C, García-Álvarez M, Vispo E, San Roman J, Sánchez-Piedra C, Soriano V, Resino S.

J Infect. 2011 Nov;63(5):382-90. doi: 10.1016/j.jinf.2011.08.006. Epub 2011 Aug 12.

PMID:
21855573
9.

Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.

Lopez-Garcia E, Schulze MB, Fung TT, Meigs JB, Rifai N, Manson JE, Hu FB.

Am J Clin Nutr. 2004 Oct;80(4):1029-35.

10.
11.

Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin.

Gustafsson S, Lind L, Söderberg S, Zilmer M, Hulthe J, Ingelsson E.

Obesity (Silver Spring). 2013 Jul;21(7):1467-73. doi: 10.1002/oby.20097. Epub 2013 Apr 13.

PMID:
23585283
12.

Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment.

Mellins CA, Tassiopoulos K, Malee K, Moscicki AB, Patton D, Smith R, Usitalo A, Allison SM, Van Dyke R, Seage GR 3rd; Pediatric HIV/AIDS Cohort Study.

AIDS Patient Care STDS. 2011 Jul;25(7):413-22. doi: 10.1089/apc.2011.0025. Epub 2011 May 5.

13.

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir.

Martínez E, D'Albuquerque PM, Llibre JM, Gutierrez F, Podzamczer D, Antela A, Berenguer J, Domingo P, Moreno X, Perez I, Pich J, Gatell JM; SPIRAL Trial Group.

AIDS. 2012 Nov 28;26(18):2315-26. doi: 10.1097/QAD.0b013e328359f29c.

PMID:
23018438
14.

Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.

Fang L, Wei H, Mak KH, Xiong Z, Song J, Wang D, Lim YL, Chatterjee S.

Can J Cardiol. 2004 Dec;20(14):1433-8.

PMID:
15614337
15.

Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth.

Mellins CA, Elkington KS, Leu CS, Santamaria EK, Dolezal C, Wiznia A, Bamji M, Mckay MM, Abrams EJ.

AIDS Care. 2012;24(8):953-62. doi: 10.1080/09540121.2012.668174. Epub 2012 Apr 23.

16.

Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth.

Nachman S, Chernoff M, Williams P, Hodge J, Heston J, Gadow KD.

Arch Pediatr Adolesc Med. 2012 Jun 1;166(6):528-35. doi: 10.1001/archpediatrics.2011.1785.

17.

T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children.

Kapetanovic S, Aaron L, Montepiedra G, Burchett SK, Kovacs A.

AIDS. 2012 May 15;26(8):959-69. doi: 10.1097/QAD.0b013e328352cee7.

19.

Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy.

Rasmussen TA, Tolstrup M, Melchjorsen J, Frederiksen CA, Nielsen US, Langdahl BL, Østergaard L, Laursen AL.

BMC Infect Dis. 2011 Oct 4;11:267. doi: 10.1186/1471-2334-11-267.

20.

Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.

Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J.

Scand J Rheumatol. 2009 Nov-Dec;38(6):439-44. doi: 10.3109/03009740903079321.

PMID:
19922018
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk